RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease
Phase III Randomized Trial of Adjuvant Involved-Field Radiotherapy vs No Adjuvant Therapy Following Remission Induction With MOPP/ABV Hybrid Chemotherapy in Patients With Stage III/IV Hodgkin's Disease
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Listed as NCT00002462, this PHASE3 trial focuses on Lymphoma and remains ongoing. Sponsored by European Organisation for Research and Treatment of Cancer - EORTC, it has been updated 10 times since 1989, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Active Not Recruiting PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Active Not Recruiting PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE3
-
Mar 2024 — Jul 2024 [monthly]
Active Not Recruiting PHASE3
-
Mar 2023 — Mar 2024 [monthly]
Active Not Recruiting PHASE3
▶ Show 5 earlier versions
-
Mar 2021 — Mar 2023 [monthly]
Active Not Recruiting PHASE3
Status: Unknown Status → Active Not Recruiting
-
Jan 2021 — Mar 2021 [monthly]
Unknown Status PHASE3
-
Aug 2019 — Jan 2021 [monthly]
Unknown Status PHASE3
Status: Active Not Recruiting → Unknown Status
-
Jun 2018 — Aug 2019 [monthly]
Active Not Recruiting PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE3
First recorded
Sep 1989
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- European Organisation for Research and Treatment of Cancer - EORTC
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
's-Gravenhage (Den Haag, the Hague), Netherlands, 's-Hertogenbosch, Netherlands, Alkmaar, Netherlands, Amsterdam, Netherlands, Antwerp, Belgium, Aviano, Italy, Blaricum, Netherlands, Bordeaux, France, Bremen, Germany, Bruges, Belgium and 34 more location s